Patient Stories

Patient portrayal of a man

Some patients experience a treatment journey that’s anything but a straight line

If you’ve been struggling with a lack of response or unmanageable side effects from your current medication for Ph+ CML in chronic phase, you’re not alone. Some patients have had to deal with the same issues—as you’ll see from the video(s) below.

Watch Al's Story

Al’s Journey

Al was diagnosed with Ph+ CML in chronic phase in 1997. Back then, there were no tyrosine kinase inhibitors (TKIs) approved for treatment of the disease. Over time, that changed and Al’s story follows the gains that have been made in treatment over the last 2 decades. Learn how Al’s journey took him from one medication to the next until his doctor of more than 20 years suggested that he participate in the clinical trials for SCEMBLIX® (asciminib) tablets.

Al’s Journey

Watch Al's Story

Al was diagnosed with Ph+ CML in chronic phase in 1997. Back then, there were no tyrosine kinase inhibitors (TKIs) approved for treatment of the disease. Over time, that changed and Al’s story follows the gains that have been made in treatment over the last 2 decades. Learn how Al’s journey took him from one medication to the next until his doctor of more than 20 years suggested that he participate in the clinical trials for SCEMBLIX® (asciminib) tablets.